Skip to main content
Premium Trial:

Request an Annual Quote

Cellzome Using Proteome Sciences' Mass Tag Tech for Proteomics Research

NEW YORK (GenomeWeb News) – Proteome Sciences will supply its tandem mass tag — or TMT — technology to German drug discovery company Cellzome, Proteome Sciences announced today.
 
Cellzome was an early beta test site for Proteome Sciences’ TMTsixplex, which allows up to six samples to be labeled, mixed, and subsequently identified. Now, Cellzome plans to apply the TMTsixplex technology to its own proteomics platform approach for analyzing protein-drug and protein-protein interactions.
 
This chemical proteomics platform uses isobaric mass tags — different forms of a molecule with the same mass — to specifically label various peptides or proteins. For instance, Cellzome is aiming to treat inflammatory diseases such as asthma and allergic rhinitis by developing drugs that target kinases. Its so-called Kinobeads are used for quantitatively measuring interactions between various compounds and kinases.
 
“We have found the TMTsixplex a useful tool for our quantitative proteomics studies,” Cellzome Director of Analytical Sciences Marcus Bantscheff said in a statement. “With this isobaric mass tagging technology we can now do six point measurements in a single mass spectrometric experiment.”
 

Financial terms of the agreement were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.